Jason Hollar

Jason Hollar
Born	Jason Hollar
Nationality	American
Occupation	Corporate executive
Title	Chief Executive Officer and Director
Employer	Cardinal Health
Known for	CEO of Cardinal Health

Jason Hollar is an American corporate executive who serves as the Chief Executive Officer and a member of the board of directors of Cardinal Health, a multinational healthcare services company headquartered in Dublin, Ohio. Cardinal Health, a Fortune 500 company, is one of the largest healthcare distributors in the United States, with revenues that have reached record levels under Hollar's leadership. Hollar assumed the role of CEO during a period of significant financial challenges for the company and subsequently led a turnaround effort that restored profitability and drove substantial revenue growth. As of early 2026, Hollar has overseen a period of expansion characterized by strategic acquisitions, operational restructuring, and a focus on both pharmaceutical distribution and the company's at-Home Solutions business. His leadership has drawn attention from investors, media, and government officials alike, placing him at the center of discussions about healthcare affordability, supply chain management, and corporate governance in the American healthcare industry.

Career

Pre-CEO Career

Prior to becoming CEO of Cardinal Health, Jason Hollar served in senior financial and operational leadership roles in the corporate sector. He joined Cardinal Health and held the position of Chief Financial Officer before being elevated to the top leadership role. His background in finance and corporate strategy informed his approach to managing one of the largest companies in the American healthcare industry.

Appointment as CEO of Cardinal Health

Hollar became CEO of Cardinal Health at a time when the company was facing considerable financial headwinds. According to Fortune magazine, the company had experienced a decline in earnings of approximately $300 million prior to Hollar's turnaround effort. The scale of the challenge required what Hollar himself described as a "ruthless" approach to restructuring and operational improvement.

Cardinal Health, which operates as a major distributor of pharmaceutical products and medical supplies across the United States and internationally, ranks among the largest companies in the country by revenue. As a Fortune 500 company with approximately $38 billion in annual revenue as reported by Fortune, the organization's performance has significant implications for the broader healthcare supply chain.

Business Turnaround

Hollar's tenure as CEO has been defined in large part by a comprehensive turnaround of Cardinal Health's financial performance. When he assumed leadership, the company was contending with declining earnings and operational inefficiencies. Hollar undertook an extensive restructuring of the business, implementing changes across the organization that he characterized as necessary to restore competitiveness and growth.

In a 2025 interview with Fortune, Hollar described his management philosophy during the turnaround, stating that he went "ruthless" in overhauling the business. Despite the scale and intensity of the changes, Hollar maintained that employees supported the effort, explaining that "people want to win." This framing positioned the restructuring not merely as a top-down cost-cutting exercise but as an effort to cultivate a performance-oriented culture throughout the organization.

The turnaround yielded measurable results. By the second quarter of fiscal year 2026, Cardinal Health had achieved record revenue levels. In an interview with The Business Journals, Hollar reflected on the magnitude of the company's growth trajectory, stating: "If I would have told investors three years ago that we'd grow like this, they wouldn't have believed me." He credited the company's Central Ohio headquarters and operations as integral to the achievement of those results.

Strategic Acquisitions and Growth

Under Hollar's leadership, Cardinal Health has pursued a strategy that balances strategic acquisitions with organic growth. The company's at-Home Solutions business, which provides home healthcare products and services, has been a particular area of focus. The acquisition of Advanced Diabetes Supply (ADS) was a notable transaction that strengthened Cardinal Health's position in the home healthcare market. According to HME News, the at-Home Solutions segment has "benefited greatly" from the ADS acquisition, which expanded the company's capabilities in diabetes supply distribution and management.

The acquisition strategy reflects a broader effort by Hollar to diversify Cardinal Health's revenue streams and position the company for long-term growth beyond its core pharmaceutical distribution business. The integration of acquired companies into Cardinal Health's operational framework has been presented by leadership as a key element of the company's growth strategy.

Healthcare Policy and Affordability Advocacy

Hollar has also engaged in public discussions about healthcare policy, particularly concerning medication affordability and access. In an October 2025 appearance on Fox Business's The Claman Countdown, Hollar discussed the importance of maintaining access to affordable medication for American patients. He addressed topics including the ongoing debate over Affordable Care Act subsidies and the role that distributors like Cardinal Health play in the healthcare supply chain. Hollar emphasized that it is "important to make sure access and affordability continues to be maintained," positioning Cardinal Health as a stakeholder in national healthcare policy discussions.

Environmental and Regulatory Scrutiny

Hollar's leadership has also intersected with regulatory and environmental concerns. In December 2025, U.S. Congresswoman Veronica Escobar of Texas sent a letter directly to Hollar expressing concern about toxic ambient air emissions at a Cardinal Health facility in El Paso, Texas. The letter followed an investigative report by El Paso Matters that examined the environmental impact of the company's operations in the area. Congresswoman Escobar requested answers from Hollar and Cardinal Health regarding the facility's emissions and the company's plans to address the issue.

The congressional inquiry placed Hollar and Cardinal Health under public scrutiny regarding the company's environmental practices and corporate responsibility. The matter highlighted the range of challenges facing the CEO of a large healthcare company, extending beyond financial performance to include environmental stewardship and community relations.

Stock Transactions

In August 2025, Hollar sold a significant number of shares in Cardinal Health, a transaction that drew attention from financial analysts and shareholders. According to Simply Wall St, the sale prompted some concern among certain Cardinal Health shareholders, though stock sales by corporate executives are a routine occurrence and may be motivated by a variety of personal and financial planning considerations. The report noted Hollar's dual role as both CEO and director of the company.

Leadership and Management Style

Hollar's management approach, as described in media interviews, centers on decisiveness and a results-oriented culture. His use of the word "ruthless" to describe his turnaround strategy at Cardinal Health conveyed an emphasis on making difficult decisions without hesitation, including restructuring operations and reallocating resources to higher-performing segments of the business.

At the same time, Hollar has emphasized the importance of employee engagement and morale in achieving corporate objectives. In his Fortune interview, he argued that employees responded positively to the turnaround because of a shared desire to be part of a winning organization. "People want to win," he stated, suggesting that clear direction and tangible results can generate internal support even during periods of significant organizational change.

Hollar has also spoken about the importance of Cardinal Health's geographic base in Central Ohio. In his February 2026 interview with The Business Journals, he highlighted the role that the Columbus, Ohio, metropolitan area plays in the company's operations and talent acquisition, describing the region as a key factor in achieving the company's record revenue performance.

As a member of Generation X, Hollar represents a cohort of corporate leaders who came of age during periods of economic transition and technological change. Fortune identified him as a "Gen X boss" in its profile of his leadership at Cardinal Health, situating him within the broader context of generational leadership dynamics in corporate America.

Public Engagement

Beyond his corporate responsibilities, Hollar has engaged with public discourse on healthcare issues through media appearances and industry events. His October 2025 Fox Business appearance addressed not only Cardinal Health's business outlook but also broader questions about the role of pharmaceutical distributors in maintaining medication affordability during a period of rising healthcare costs and evolving federal policy.

Hollar has also been the recipient of correspondence from elected officials on matters of public concern, as illustrated by the December 2025 letter from Congresswoman Escobar. Such interactions reflect the extent to which the CEO of a major healthcare company operates at the intersection of business, regulation, and public health policy.

Cardinal Health Under Hollar

Cardinal Health, under Hollar's stewardship, has pursued growth across multiple business segments. The company's pharmaceutical distribution business remains its largest segment, supplying medications and healthcare products to hospitals, pharmacies, and other healthcare providers across the United States. The at-Home Solutions business, bolstered by the acquisition of Advanced Diabetes Supply, has expanded the company's presence in the growing home healthcare market.

The company's financial trajectory under Hollar has been marked by a recovery from the pre-turnaround earnings decline to record revenues by early 2026. Hollar's assertion to The Business Journals that investors three years prior would not have believed the company's growth trajectory underscores the scale of the financial improvement achieved during his tenure.

Cardinal Health's headquarters remain in Dublin, Ohio, a suburb of Columbus. Hollar has publicly emphasized the strategic advantages of the company's Central Ohio location, including access to a skilled workforce and a central geographic position within the United States that supports the company's nationwide distribution operations.

The company trades on the New York Stock Exchange under the ticker symbol CAH and is included in the Fortune 500 ranking of the largest American corporations by revenue.

Recognition

Hollar's turnaround of Cardinal Health has received substantial coverage in national business media. Fortune magazine profiled his leadership in a July 2025 feature that examined the strategies he employed to reverse the company's earnings decline and restore growth. The profile positioned Hollar as an example of effective crisis management and corporate restructuring in the healthcare sector.

The Business Journals highlighted Hollar's achievement of record revenue at Cardinal Health in its February 2026 coverage, quoting his reflections on the improbability of the company's growth trajectory as perceived by investors just three years earlier.

His media appearances, including the Fox Business interview in October 2025, have provided Hollar with a platform to discuss both Cardinal Health's business strategy and broader healthcare policy issues, raising his profile within the industry and among investors.